Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. 

Deadlines:

  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PAR-19-368 Expiration Date September 8, 2021

Agency Website

Amount Description

Budgets may request no more than $499,999 direct costs per year and must reflect the actual needs of the proposed project.

 The maximum period is 5 years, however period requested should reflect the actual needs of the proposed project and applicants requesting the maximum will be required to justify why the full time is needed. 

    Funding Type

    Grant

    Eligibility

    Faculty

    Category

    Interdisciplinary
    Medical
    Medical - Basic Science
    Medical - Clinical Science
    Social Sciences

    External Deadline

    June 5, 2020